Earlier this month, the Trump administration directed the National Institutes of Health (NIH) to impose limits on specific types of funding it provides to ...

Last year, more than $7.5 billion globally went to companies applying advances in artificial intelligence to health-related areas such as medical services and pharmaceutical development, per ...

In 2024, global private equity and venture capital transaction value and volume in biotechnology declined to their lowest ...

Germany's Kynda has raised €3M in seed funding to expand production of its mycelium meat, which is made from upcycled food ...

Artificial intelligence (AI) has emerged as an influential technology, driving notable investments across various industries ...

For 2025, a rebound may be in store for investments in digital health startups, according to a recent survey report from Summit Health Advisors.

Latent Labs, an AI biotech startup, has emerged from stealth mode with a remarkable $50 million funding boost. Founded by a ...

Venture capital hit a record €1.5bn in Ireland in 2024, according to new industry figures. An unprecedented €585m fourth quarter saw Irish tech, biotech and medical device firms attract a total of €1.

A pharma giant expresses interest in a Stamford biotech company after striking a deal worth up to $1.3 billion for a New ...

On August 15, Tevogen Bio entered into a definitive agreement for a $6 million Series C Preferred Stock investment (“Series C”). The shares of the Series C have a 7.5% annual dividend and are ...

The Crimson spoke to a range of commercial realtors, startup founders, and a commercial lab space owner to understand how the immense draw of Kendall Square has forced the myriad startup companies ...

What are "indirect costs" for universities? Why are some young scientists looking at opportunities abroad? And why are AI ...